What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company. It is focused on discovering, developing, and manufacturing a wide range of healthcare products. The company's operations span four key segments: Established Pharmaceuticals; Diagnostics; Nutritional Products; and Medical Devices.

Shares of Abbott Laboratories have underperformed the broader market over the past 52 weeks. ABT stock has risen 24.5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 36.1%. In 2024, shares of ABT are up 6.3%, compared to SPX's 26% gain on a YTD basis.